Tormere Analytics
OverviewStock ResearchPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Pricing
Privacy PolicyTerms of Service

TLSI

$4.70-0.63%

TriSalus Life Sciences, Inc.

Market Cap
$293M
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Beta
0.44
5yr monthly vs SPY
Price Chart
Loading…

Signals

Insider Velocity
27.1x
buying
Congress
—
recent trades
Short Volume
54%
W/W +19.2pp

Market & Alt Data

News
8
recent articles
Activist
13D
TriSalus
Analyst Consensus
Strong Buy
10 analysts

Buy Activity

Buy Velocity Score
27.08x
Current Rate (90d)
8075.36/mo
Baseline Rate
0.00/mo
Unique Buyers (90d)
5

Sell Activity

Sell Velocity Score
27.08x
Sell Rate (90d)
380.26/mo
Sell Baseline
0.00/mo
Unique Sellers (90d)
5
Sort by
Type
Trade DateFiledOwnerRoleTypeSharesPriceValueOwned After
2026-05-152026-05-19Marshak RichardChief Commercial OfficerSale543$2.67$1K125.1KView
2026-05-152026-05-18Stansky Michael PDirectorPurchase610.0K$2.50$1.52M1.24MView
2026-05-152026-05-18Szela Mary TDirector & CEO and PresidentPurchase39.7K$2.59$103K1.07MView
2026-05-152026-05-18Patience DavidChief Financial OfficerPurchase7,100$2.43$17K275.8KView
2026-05-152026-05-18Gordon Gary B.DirectorPurchase10.0K$2.46$25K72.5KView
1–5 of 27
1 / 6

Recent News

TriSalus Life Sciences to Participate in the H.C. Wainwright & Company 28th Annual Global Investment Conference
Yahoo Finance · 2026-08-31
TriSalus Highlights Tumor-Treatment Expansion, FDA Catalyst at Growth Conference
Yahoo Finance · 2026-08-18
TriSalus Life Sciences Q2 Earnings Call Highlights
Yahoo Finance · 2026-08-07
TriSalus Life Sciences Inc (TLSI) (Q2 2026) Earnings Call Highlights: New CMS G-code Expands ...

Informational purposes only, not investment advice.

Yahoo Finance · 2026-08-07
TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Liver Cancer
Yahoo Finance · 2026-06-10
TriSalus Life Sciences Inc (TLSI) Q1 2026 Earnings Call Highlights: Strategic Expansion and ...
Yahoo Finance · 2026-05-13
TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates
Yahoo Finance · 2026-05-12
TriSalus (TLSI) Initiates Patient Enrollment for PREDICTT Liver Tumor Clinical Trial
Yahoo Finance · 2026-05-10

Factor Profile

Pro
Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →
Pipeline
Active
1 active trial